Tae-Hoon Shin

Tae-Hoon Shin

Auto-generated profile, based on publicly available information

Tae-Hoon Shin

Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Blood
Verified
Journal Article
Open access
PDF file
TSTae-Hoon Shin
Tae-Hoon Shin
YZYifan Zhou
Yifan Zhou
SCShirley Chen
Shirley Chen
SCStefan Cordes
Stefan Cordes
MGMax Z. Grice
Max Z. Grice
CDCynthia E. Dunbar
Cynthia E. Dunbar
Individuals with age-related clonal hematopoiesis (CH) are at greater risk for hematologic malignancies and cardiovascular diseases. However, predictive preclinical animal models to recapitulate the spectrum of human CH are lacking. Through error-corrected sequencing of 56 human CH/myeloid malignancy genes, we identified natural CH driver mutations in aged rhesus macaques matching genes somatically mutated in human CH, with DNMT3A mutations being the most frequent. A CH model in young adult macaques was generated via autologous transplantation of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9–mediated gene-edited hematopoietic stem and progenitor cells (HSPCs), targeting the top human CH genes with loss-of-function (LOF) mutations. Long-term follow-up revealed reproducible and significant expansion of multiple HSPC clones with heterozygous TET2 LOF mutations, compared with minimal expansion of clones bearing other mutations. Although the blood counts of these CH macaques were normal, their bone marrows were hypercellular and myeloid-predominant. TET2-disrupted myeloid colony-forming units isolated from these animals showed a distinct hyperinflammatory gene expression profile compared with wild type. In addition, mature macrophages purified from the CH macaques showed elevated NLRP3 inflammasome activity and increased interleukin-1β (IL-1β) and IL-6 production. The model was used to test the impact of IL-6 blockage by tocilizumab, documenting a slowing of TET2-mutated expansion, suggesting that interruption of the IL-6 axis may remove the selective advantage of mutant HSPCs. These findings provide a model for examining the pathophysiology of CH and give insights into potential therapeutic interventions.

6 June 2019 in Blood
Verified
Journal Article
Closed access
TSTae-Hoon Shin
Tae-Hoon Shin
EBEun Jung Baek
Eun Jung Baek
MCMarcus A. F. Corat
Marcus A. F. Corat
SCShirley Chen
Shirley Chen
JMJean-Yves Metais
Jean-Yves Metais
CDCynthia E. Dunbar
Cynthia E. Dunbar

19 July 2022 in Blood
Verified
Journal Article
Open access
PDF file
YZYifan Zhou
Yifan Zhou
RSRuba Shalhoub
Ruba Shalhoub
SRStephanie N. Rogers
Stephanie N. Rogers
SYShiqin Yu
Shiqin Yu
MGMuxin Gu
Muxin Gu
GVGeorge S. Vassiliou
George S. Vassiliou

7 June 2016 in Oncotarget
Verified
Journal Article
Open access
SCSoon Won Choi
Soon Won Choi
JSJi-Hee Shin
Ji-Hee Shin
JKJae-Jun Kim
Jae-Jun Kim
TSTae-Hoon Shin
Tae-Hoon Shin
YSYoojin Seo
Yoojin Seo
KKKyung-Sun Kang
Kyung-Sun Kang
Direct cell fate conversion of human somatic stem cells into cone and rod photoreceptor-like cells by inhibition of microRNA-203

24 January 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
ARAndrew R. Rahmberg
Andrew R. Rahmberg
CWChuanfeng Wu
Chuanfeng Wu
TSTaehoon Shin
Taehoon Shin
SHSo Gun Hong
So Gun Hong
LPLuxin Pei
Luxin Pei
JBJason M. Brenchley
Jason M. Brenchley
Macrophages orchestrate tissue immunity from the initiation and resolution of antimicrobial immune responses to the repair of damaged tissue. Murine studies demonstrate that tissue-resident macrophages are a heterogenous mixture of yolk sac–derived cells that populate the tissue before birth, and bone marrow–derived replacements recruited in adult tissues at steady-state and in increased numbers in response to tissue damage or infection. How this translates to species that are constantly under immunologic challenge, such as humans, is unknown. To understand the ontogeny and longevity of tissue-resident macrophages in nonhuman primates (NHPs), we use a model of autologous hematopoietic stem progenitor cell (HSPC) transplantation with HSPCs genetically modified to be marked with clonal barcodes, allowing for subsequent analysis of clonal ontogeny. We study the contribution of HSPCs to tissue macrophages, their clonotypic profiles relative to leukocyte subsets in the peripheral blood, and their transcriptomic and epigenetic landscapes. We find that HSPCs contribute to tissue-resident macrophage populations in all anatomic sites studied. Macrophage clonotypic profiles are dynamic and overlap significantly with the clonal hierarchy of contemporaneous peripheral blood monocytes. Epigenetic and transcriptomic landscapes of HSPC-derived macrophages are similar to tissue macrophages isolated from NHPs that did not undergo transplantation. We also use in vivo bromodeoxyuridine infusions to monitor tissue macrophage turnover in NHPs that did not undergo transplantation and find evidence for macrophage turnover at steady state. These data demonstrate that the life span of most tissue-resident macrophages is limited and can be replenished continuously from HSPCs.

2 July 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YSYoojin Seo
Yoojin Seo
JAJi-Su Ahn
Ji-Su Ahn
YSYe Young Shin
Ye Young Shin
SOSu-Jeong Oh
Su-Jeong Oh
MSMin-Hye Song
Min-Hye Song
HKHyung-Sik Kim
Hyung-Sik Kim
Olfactory loss has been considered as the earliest complication for the aging process while underlying mechanisms and therapeutic strategies remain unclear. Given the correlation between microglial activation and olfactory dysfunction, here we investigated whether the immunomodulatory action of mesenchymal stem cells (MSCs) can rescue the olfactory impairment in old mice. The intranasal delivery of MSCs limited microglial activation and neuronal apoptosis in the olfactory bulb (OB), leading to improvement in olfaction. MSCs down-regulated the proportion of CD86+ microglia and prevented the maturation of cathepsin S, one of the inflammatory mediators in olfactory impairment, via the suppression of p38 MAPK signaling. Notably, old astrocytes could not prevent excessive microgliosis because the endogenous production of Galectin-1 (Gal1), one of the key microglia regulators secreted by astrocytes, was not sufficiently upregulated in the aged brain despite the presence of reactive astrogliosis. Considering that Gal1 is known as a potent paracrine factor of MSCs, we investigated whether MSC-derived Gal1 could compensate for defective astrocyte function in terms of microglial regulation. MSCs and their culture supernatant (MSC-CM) could regulate the direction of microglial differentiation by impeding the polarization towards the pro-inflammatory M1 type; notably, a selective Gal1 inhibitor OTX008 could hinder this phenomenon, indicating that Gal1 is involved in immunomodulation exerted by MSCs. Also, acute microglial activation within the OB upon LPS infusion was attenuated by MSC-CM in a Gal1-dependent manner. Our study demonstrates the therapeutic benefit of MSCs on age-related olfactory dysfunction and suggests Gal1 as a key mediator of the anti-inflammatory action of MSCs.